Treatment of dermatological pathologies
US9902769B2 · kind B2 · utility
1Cited by
0References
6Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 31, 2016 |
| Grant date | Feb 27, 2018 |
| Priority date | — |
| Expiry date | Aug 31, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Skin inflammation in a human subject is reduced by administering to the subject a pharmaceutical composition that includes a pharmaceutically acceptable carrier and a therapeutically effective amount of an agent that selectively binds IL-1α.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.